Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2008

View Archived Issues

Indibulin well tolerated, active in patients with advanced solid tumors

DTS-108 may represent an improvement over irinotecan

Abacavir, didanosine linked to increased risk of myocardial infarction

Nebicapone increases levodopa exposure in Parkinson's disease patients

PHX-1149 effective in proof-of-concept study in type 2 diabetes patients

Collegium filed supplemental NDA for approval of AllerNase for allergic rhinitis

Phase I study of ENMD-2076 begins in advanced cancer patients

Otelixizumab set to enter phase III for new-onset type 1 diabetes

Cationorm launched in France for dry eye symptoms

Novel CGRP antagonist profiled at Merck & Co.

Iomai receives grant to develop patch-based anthrax vaccine

Critical Therapeutics completes phase I clinical trial of (R)-zileuton

Exubera labeling updated in the United States

Seattle Genetics initiates phase Ib clinical trial of SGN-40 in non-Hodgkin's lymphoma

Novartis' ACZ-885 shows potential in treating serious life-long autoinflammatory conditions

Teverelix LA demonstrates testosterone suppression in prostate cancer study

BGC-20-0166 shows potential for obstructive sleep apnea

OVax cleared to begin phase I/II trial in ovarian cancer

Aerosolized ALN-RSV01 begins phase II trial in adult RSV

Pivotal phase III trial commences for novel cancer agent ASA-404

FDA approves Lexiscan as an agent in myocardial perfusion imaging

Crucell enters research license agreement with Celltrion to evaluate Star production technology

FDA extends action date for priority review of Amgen's BLA for romiplostim in ITP

Recent patents disclose novel antidiabetic agents

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...